Chronic Hepatitis C Virus Genotype 6 Infection: Response to Pegylated Interferon and Ribavirin
Author(s) -
James Fung,
ChingLung Lai,
Ivan FanNgai Hung,
John Young,
Charles Cheng,
Danny Wong,
ManFung Yuen
Publication year - 2008
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/591252
Subject(s) - ribavirin , pegylated interferon , virology , genotype , medicine , interferon , hepatitis c virus , virus , immunology , hepacivirus , biology , gene , biochemistry
To date, no study has evaluated pegylated interferon for the treatment of chronic infection with hepatitis C virus (HCV) genotype 6. We aimed to determine the efficacy of pegylated interferon plus ribavirin for treating infection with genotype 6 versus genotype 1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom